Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Vortex launches clinical study using liquid biopsy technology to advance cancer monitoring

      Vortex Liquid Biopsy Solutions has launched a clinical study [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Orano Med and Roche move two-step 212Pb therapy into clinical development

    Orano Med has advanced its long-running collaboration with Roche as [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Saphnelo self-administration recommended for EU approval for systemic lupus

    AstraZeneca has received a positive recommendation from the Committee for [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Pistoia Alliance warns of scientific content crisis limiting accuracy of AI in life sciences R&D

    The Pistoia Alliance has reported new findings pointing to a [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    €1 million investment for BiPER Therapeutics to launch BPR001-615 BiP inhibitor trial

    BiPER Therapeutics has raised €1 million ($1.16M) to support the [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    One-carbon Therapeutics secures SEK 153 million (€13.9 million) to expand Odin trial

    One-carbon Therapeutics has secured SEK 153 million (€13.9 million) in [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    CNS Pharmaceuticals announces primary analysis of Berubicin in second line treatment of glioblastoma multiforme

    CNS Pharmaceuticals has reported the primary analysis of its clinical [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Horiba UK launches philanthropic foundation to advance scientific research and broaden STEM participation

    Horiba UK has launched the Horiba Foundation UK, a new [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Macomics updates Enigmac platform data and highlights macrophage role in fibrotic disease

    Macomics has released new data supporting the use of its [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Veeva announces expanded partnership with Roche to deliver next-generation AI CRM

    Veeva Systems has extended its partnership with Roche Pharmaceuticals by [...]

    May 5, 2026
Previous383940Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Limbic selected for FDA pilot to test AI-led mental healthcare
    Categories: Central Nervous System, Clinical & Regulatory, Digital & Data, Pharmaceuticals and therapeutics, Therapeutic Areas
  • APAC ablation catheter market set to grow 14% as pulsed field ablation gains ground
    Categories: Medical devices
  • Andelyn and Queen’s University partner on AAV9 gene therapy for GM2 gangliosidoses
    Categories: Advanced Therapies, Drug Discovery & Development, Manufacturing & Supply Chain, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top